n(g),n(g')-dimethyl-l-arginine has been researched along with Cerebral Infarction in 5 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to investigate the distribution of plasma asymmetrical dimethylarginine (ADMA) and homocysteine levels in Chinese patient with acute cerebral infarction (ACI) and their correlations with various risk factors." | 7.80 | Risk of acute cerebral infarction and plasma asymmetrical dimethylarginine and homocysteine levels: a clinical correlation analysis of Chinese population. ( Dong, Q; Li, X; Wang, Y; Zhang, F; Zhang, H, 2014) |
| " Although asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, is associated with atherosclerotic disease, there has been no report on association of ADMA with ischemic stroke." | 7.71 | Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. ( Lee, SC; Yoo, JH, 2001) |
| "The aim of this study was to investigate the distribution of plasma asymmetrical dimethylarginine (ADMA) and homocysteine levels in Chinese patient with acute cerebral infarction (ACI) and their correlations with various risk factors." | 3.80 | Risk of acute cerebral infarction and plasma asymmetrical dimethylarginine and homocysteine levels: a clinical correlation analysis of Chinese population. ( Dong, Q; Li, X; Wang, Y; Zhang, F; Zhang, H, 2014) |
| " Although asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, is associated with atherosclerotic disease, there has been no report on association of ADMA with ischemic stroke." | 3.71 | Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. ( Lee, SC; Yoo, JH, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, F | 1 |
| Li, X | 1 |
| Dong, Q | 1 |
| Wang, Y | 1 |
| Zhang, H | 1 |
| Zhang, Y | 1 |
| Fan, D | 1 |
| Zhang, N | 1 |
| Notsu, Y | 1 |
| Nabika, T | 1 |
| Bokura, H | 1 |
| Suyama, Y | 1 |
| Kobayashi, S | 1 |
| Yamaguchi, S | 1 |
| Masuda, J | 1 |
| Wanby, P | 1 |
| Teerlink, T | 1 |
| Brudin, L | 1 |
| Brattström, L | 1 |
| Nilsson, I | 1 |
| Palmqvist, P | 1 |
| Carlsson, M | 1 |
| Yoo, JH | 1 |
| Lee, SC | 1 |
5 other studies available for n(g),n(g')-dimethyl-l-arginine and Cerebral Infarction
| Article | Year |
|---|---|
Risk of acute cerebral infarction and plasma asymmetrical dimethylarginine and homocysteine levels: a clinical correlation analysis of Chinese population.
Topics: Aged; Arginine; Asian People; Case-Control Studies; Cerebral Infarction; China; Female; Homocysteine | 2014 |
[The relationship between serum asymmetric dimethylarginine and ABCD2 score in transient ischemic attack patients].
Topics: Arginine; Case-Control Studies; Cerebral Infarction; Humans; Ischemic Attack, Transient; Risk Factor | 2014 |
Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
Topics: Arginine; Arteriosclerosis; Biomarkers; Blood Pressure; Brain Damage, Chronic; Cerebral Infarction; | 2009 |
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.
Topics: Acute Disease; Aged; Arginine; Biomarkers; Cerebral Hemorrhage; Cerebral Infarction; Enzyme Inhibito | 2006 |
Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
Topics: Aged; Aged, 80 and over; Arginine; Cerebral Infarction; Chromatography, High Pressure Liquid; Enzyme | 2001 |